Brain tumor biomarkers for research, clinics, and registries - The 2021 Brain Tumor Epidemiology Consortium meeting report.

IF 0.8 4区医学 Q4 CLINICAL NEUROLOGY

Clinical Neuropathology Pub Date : 2021-11-01 DOI:10.5414/NP301437

Kimberly J Johnson, Judith Schwartzbaum, Carol Kruchko, Luc Bauchet, Quinn Ostrom, Michael E Scheurer, Johannes A Hainfellner, Helle Broholm

引用次数: 0

Abstract

The Brain Tumor Epidemiology Consortium (BTEC) is an international consortium that fosters interdisciplinary collaborations focusing on research related to the etiology, outcomes, and prevention of brain tumors. The 21^st annual BTEC meeting with the theme "Brain Tumor Biomarkers for Research, Clinics, and Registries" was held virtually from June 22 to 24, 2021. Scientists from North America and Europe, representing a broad range of brain tumor research interests, presented recent research and progress in the field. The meeting content is summarized in the following report.

查看原文本刊更多论文

用于研究、临床和登记的脑肿瘤生物标记物 - 2021 年脑肿瘤流行病学联合会会议报告。

脑肿瘤流行病学联盟（BTEC）是一个促进跨学科合作的国际联盟，其研究重点是脑肿瘤的病因、结果和预防。第 21 届 BTEC 年会于 2021 年 6 月 22 日至 24 日举行，主题是 "用于研究、临床和登记的脑肿瘤生物标志物"。来自北美和欧洲的科学家代表了广泛的脑肿瘤研究兴趣，介绍了该领域的最新研究和进展。会议内容摘要如下。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Neuropathology 医学-病理学

CiteScore

1.60

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Clinical Neuropathology appears bi-monthly and publishes reviews and editorials, original papers, short communications and reports on recent advances in the entire field of clinical neuropathology. Papers on experimental neuropathologic subjects are accepted if they bear a close relationship to human diseases. Correspondence (letters to the editors) and current information including book announcements will also be published.